INOVIO PHARMACEUTICALS, INC. - 10-Q Filing

Inovio Pharmaceuticals reports financial position for the period ending September 30, 2026, featuring significant warrant activity and equity adjustments.

SEC EDGAR ·

Tickers: $INO

Read the full article at SEC EDGAR

More Regulatory news